Table I. Targeted schedule and timeline for Phase I * - indicates steps that can be performed in parallel Step Estimated Duration, cost From start of phase Milestones [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] The proposed Phase II timeline encompasses use of the [***].
Table I and “Table II” means the correspondingly numbered lists of substances annexed to this Convention, as amended from time to time in accordance with article 12;
Table I. Means and Standard Deviations of the MSL for the Three Configurations Closest to the MSL and FWHM Thresholds CROSSING OVER THE THREE FREQUENCY BANDS, AS [180 Hz, 600 Hz] (LOW), [600 Hz, 1250 Hz] (MEDIUM), AND [1250 Hz, 2 kHz] (HIGH) −− Fig. 3. Array configurations for different geometries within the mean MSL/mean FWHM space. Each marker represents an array shape: conical tip up (CU), conical tip down (CD), cylindrical four circles (C4), spherical (Sp), and cylindrical two circles (C2). The frequency bands used for averaging are [160 Hz, 2 kHz] for the MSL and [180 Hz, 2 kHz] for the FWHM. represents both the MSL and FWHM thresholds given in Section II-A. frequency band for all of the tested cases, to yield the solution that has the most uniform performance. This is a requirement for the array, as wideband signal recordings are expected as input. This method allows visual and synthetic representation of the performance of various array configurations, by plotting each one in the mean MSL/mean FWHM space, as seen in the array conception in Section IV. Consequently, the array that approaches the nearest to the thresholds defined in Section II can be easily selected from this synthesized view of the array performances.
Examples of Table I in a sentence
All relevant physiological parameter values are summarized in Table I.
It will include, thus: Costs for managing the Agreement The amount of ________________ + VAT (Table I of Annex II) is established to be paid for management of the Agreement and the payment will be made on presentation of the corresponding invoice at the same time that the Agreement is ready for signatures.
The baseline clinical and angiographic characteristics are shown in Table I.
The cache reduces the L2 handoff time to only a few milliseconds (see Table I) and cache misses due to errors in movement prediction introduce only a few milliseconds of have such information by sending an INFOREQ multicast frame.
As noted in Table I, of the two previous studies that examined self-reported sleep and similar hypertensive disorders during pregnancy, one also failed to observe significant associations (Reutrakul et al.
More Definitions of Table I
Table I. School Funding System Weights Weighted Group Description of the Weighted Group Weight Weighted Group Description of the Weighted Group Weight Weighted Group Description of the Weighted Group Weight Table II: Portion of LEA Funding Allocated Through System Row 1 Column A Column B Column C Column D Column E Row 2 Funds Fiscal Year Total Funding Amount of Funds Allocated Through System Percentage of Funds Allocated Through System
Table I. Core OTI Patent--Method for the Non-Contact Transmission of Data ---------------------------------------------------------------------------------------------------------- Filed Patent Country Number Date Number Date Status ---------------------------------------------------------------------------------------------------------- X.X. 000000 0/0/00 0000000 00/0/00 Xxxxted Israel 100451 20/12/91 100451 10/10/96 Granted Canada 2053830 23/12/91 2058330 8/1/99 Allowance Singapore 9607564/3 23/00/00 0000000/0 00/0/00 Xxxxxed Australia 90011/91 24/12/91 640843 8/1/94 Granted South Africa 91/10164 27/00/00 00/00000 30/9/92 Granted Hong Kong 97101652.1 12/8/97 Pending EUROPE 91122099.4 23/12/91 0 492 569 4/11/98 Granted Germany Europe 691-30-447-05-08 04/11/98 Granted Italy Europe 192090E/99 13/1/99 Granted Austria Europe 0 492 569 2/2/99 Granted Denmark Europe P199801745 21/1/99 Granted Sweden Europe 0 492 569 26/1/99 Granted Netherlands Xxxxxx 0 000 000 4/11/98 Granted Greece Europe 990400178 18/1/99 Granted Switzerland Europe 0 492 569 4/11/98 Granted Belgium Europe 0 492 569 4/11/98 Granted Spain Europe ES 2125860 T3 4/11/98 Granted France Europe 0 492 569 4/11/98 Granted UK Europe Luxembourg Europe ----------------------------------------------------------------------------------------------------------
Table I. I: Projected Impact of HHK subsidies on the LPG subsector and the economy Year (A) HHK 10% of Actual Additional Total (F) % Increase Subsidy in HHK 12.5kg 12.5kg to be =D+E (G) Billion Naira (B) Subsidy to be Used (C) Figures (D) Generated by Subsidy (E) 2006 88.456 8.8456 4,640,000 5,897,066 10.537,066 127.0 2007 90.814 9.0814 4,800,000 5,342,000 10,142,000 111.0 2008 188.554 18.8554 8,000,000 9,427,700 17,427,700 118.0
Table I. Means (standard deviations) of selected variables IJM 25,3/4
Table I. Means, standard deviations, Cronbachalphas, and correlations among variablesstudied a(N varies from 251 to 281) M SD 1 2 3 4 5 6 7 8 91. LMX 3.79 0.59 (0.77)2. Transformational leadership 3.49 0.72 ****0.62 (0.88)3. Value system congruence 0.70 0.20 **0.14 ****0.294. Assertiveness 2.30 0.68 0.08 0.07 0.01 (0.65)5. Bargaining 2.42 0.88 0.01 0.05 0.10 ****0.46 (0.72)6. Coalition 2.98 1.05 0.03 0.06 0.09 ****0.35 ****0.35 (0.59)7. Friendliness 3.26 0.64 ***0.16 ***0.19 0.01 **0.12 ****0.30 ****0.22 (0.53)8. Higher authority 2.01 0.67 ** 0.15 ** 0.12 0.04 ****0.51 ****0.41 ****0.30 ***0.19 (0.56)9. Reasoning 3.99 0.67 ****0.31 ****0.21 0.01 ****0.28 *0.11 ***0.19 ****0.24 0.06 (0.59)Notes : a Cronbach alpha is in parentheses along diagonal.*= p 0.10. **= p 0.05. ***= p 0.01. ****= p 0.001related to perceived value system congruence. I followed the procedure suggested by Baron and Kenny (1986) to test my Hypothesis 1 that transformational leadership would mediate the relationship between LMX and leader-follower value system congruence. Transformational leadership was first regressed on LMX; the model was significant at 0.001 level (R-Square 0.38) and the parameter estimate of LMX was 0.75 (t 13.13,Impact of transformationalleadership
Table I. Means, standard deviations, and correlations: study 1 On passion and heavy work investment
Table I. Milestone Chart and Schedule Milestone Payment [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] ActiveUS 170463621v.1 Annex 2 Phase II clinical study protocol (The draft version will be subjected to revision according regulatory authorities’ review; This contract will be conducted according to the approved version).